FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
This month, the editors selected studies comparing CAR T therapies for large B-cell lymphoma, assessing a new type of...
This Halloween edition features ghostly transparent mice, parasites to deliver drugs to the brain, stealing from the dead, and...
The AACR Industry Roundtable 2024 focused on topics related to tracking and treating early cancers, including predicting cancer risk...
Janet Mosugu, recipient of the Margaret Foti Scholarship, wants to use communication to help empower communities take charge of...
The 16th Frontiers in Cancer Science conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Andrew Chapman and Kuang-Yi Wen of Thomas Jefferson University were named scientific awardees for their work in geriatric oncology...
By Bob Riter, Patient Advocate, Cornell Community Cancer Partnership When I was diagnosed with stage 2 breast cancer about...
Changes to sexual health during breast cancer treatment can impact quality of life and treatment adherence—especially in Black women.
The AACR Special Conference: Liquid Biopsy features experts exploring all facets of this exciting technological arena.